Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, Spain

Meat Science

Volumn 93, Issue 2, 2013, Pages 316-321

  Ojer Usoz, Elena ^a   González, David ^a   Vitas, Ana Isabel ^a   Leiva, José ^b   García Jalón, Isabel ^a   Febles Casquero, Alejandro ^b   Escolano, María de la Soledad ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Enterobacteriaceae; ESBL; Extended spectrum lactamase; Meat products

Indexed keywords

AGAR PLATES; AMOXICILLIN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; DIFFUSION METHOD; DOXYCYCLINE; ENTEROBACTERIACEAE; ESBL; FOSFOMYCIN; HIGH RATE; LACTAMASES; LOW RATES; MEAT PRODUCTS; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX PCR; NORFLOXACIN; PIPERACILLIN; PREDOMINANT BACTERIA;

ACID RESISTANCE; ANTIBIOTICS; ESCHERICHIA COLI;

MEATS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI;

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIZOXIME; DRUG DERIVATIVE;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; CATTLE; DRUG EFFECT; ENTEROBACTERIACEAE; FOOD CONTAMINATION; FOOD CONTROL; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MEAT; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; POULTRY; PREVALENCE; SPAIN; SWINE;

ANIMALS; ANTI-BACTERIAL AGENTS; AZTREONAM; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CATTLE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; FOOD CONTAMINATION; FOOD MICROBIOLOGY; MEAT PRODUCTS; MICROBIAL SENSITIVITY TESTS; POULTRY; PREVALENCE; SPAIN; SWINE;

EID: 84868629485     PISSN: 03091740     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meatsci.2012.09.009     Document Type: Article

References (50)

1. Aarestrup F.M. Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. International Journal of Antimicrobial Agents 1999, 12(4):279-285.
2. Allen H.K., Donato J., Wang H.H., Cloud-Hansen K.A., Davies J., Handelsman J. Call of the wild: Antibiotic resistance genes in natural environments. Nature Reviews. Microbiology 2010, 8(4):251-259.
3. Amador P., Fernandes R., Prudencio C., Brito L. Resistance to beta-lactams in bacteria isolated from different types of Portuguese cheese. International Journal of Molecular Sciences 2009, 10(4):1538-1551.
4. Angulo F.J., Nargund V.N., Chiller T.C. Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. Journal of Veterinary Medicine Series B 2004, 51(8-9):374-379.
5. Bauer A.W., Kirby W.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 1966, 45(4):493-496.
6. Bergenholtz R.D., Jorgensen M.S., Hansen L.H., Jensen L.B., Hasman H. Characterization of genetic determinants of extended-spectrum cephalosporinases (ESCs) in Escherichia coli isolates from Danish and imported poultry meat. The Journal of Antimicrobial Chemotherapy 2009, 64(1):207-209.
7. Blanco M., Alonso M.P., Nicolas-Chanoine M.H., Dahbi G., Mora A., Blanco J.E., et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases in Lugo (Spain): Dissemination of clone O25b:H4-ST131 producing CTX-M-15. The Journal of Antimicrobial Chemotherapy 2009, 63(6):1135-1141.
8. BOE Real decree 1376/2003 (7 November 2003) on the conditions for production, storage and marketing of meat and meat establishments in retail trade. BOE no. 273, 14/11/2003 2003, Boletín Oficial de Estado, Madrid, Spain.
9. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews 2001, 14(4):933-951. (table of contents).
10. Briñas L., Moreno M.A., Teshager T., Sáenz Y., Porrero M.C., Domínguez L., et al. Monitoring and characterization of extended-spectrum beta-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrobial Agents and Chemotherapy 2005, 49(3):1262-1264.
11. Briñas L., Moreno M.A., Zarazaga M., Porrero C., Sáenz Y., García M., et al. Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrobial Agents and Chemotherapy 2003, 47(6):2056-2058.
12. Carattoli A. Animal reservoirs for extended spectrum beta-lactamase producers. Clinical Microbiology and Infection 2008, 14(Suppl. 1):117-123.
13. Carneiro C., Araujo C., Goncalves A., Vinué L., Somalo S., Ruiz E., et al. Detection of CTX-M-14 and TEM-52 extended-spectrum beta-lactamases in fecal Escherichia coli isolates of captive ostrich in Portugal. Foodborne Pathogens and Disease 2010, 7(8):991-994.
14. CLSI Clinical and Laboratory Standards Institute. M100-S20. Performance standards for antimicrobial susceptibility testing: 21th informational supplement 2010, CLSI, Wayne, PA, Clinical and Laboratory Standards Institute.
15. Colom K., Pérez J., Alonso R., Fernández-Aranguiz A., Larino E., Cisterna R. Simple and reliable multiplex PCR assay for detection of blaTEM, bla(SHV) and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiology Letters 2003, 223(2):147-151.
16. Cortes P., Blanc V., Mora A., Dahbi G., Blanco J.E., Blanco M., et al. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Applied and Environmental Microbiology 2010, 76(9):2799-2805.
17. Costa D., Vinué L., Poeta P., Coelho A.C., Matos M., Sáenz Y., et al. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers. Veterinary Microbiology 2009, 138(3-4):339-344.
18. Díaz M.A., Hernández-Bello J.R., Rodríguez-Baño J., Martínez-Martínez L., Calvo J., Blanco J., et al. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: Second nationwide study. Journal of Clinical Microbiology 2010, 48(8):2840-2845.
19. Dierikx C., van Essen-Zandbergen A., Veldman K., Smith H., Mevius D. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Veterinary Microbiology 2010, 145(3-4):273-278.
20. EFSA The community summary report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2004-2007. EFSA Journal 2010, Vol. 8:1309. European Food Safety Authority.
21. EFSA Scientific opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA Journal 2011, 9:2322. European Food Safety Authority.
22. Escudero E., Vinué L., Teshager T., Torres C., Moreno M.A. Resistance mechanisms and farm-level distribution of fecal Escherichia coli isolates resistant to extended-spectrum cephalosporins in pigs in Spain. Research in Veterinary Science 2010, 88(1):83-87.
23. Gniadkowski M. Evolution of extended-spectrum beta-lactamases by mutation. Clinical Microbiology and Infection 2008, 14(Suppl. 1):11-32.
24. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., Pascual A. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrobial Agents and Chemotherapy 2005, 49(5):2122-2125.
25. Hughes L., Hermans P., Morgan K. Risk factors for the use of prescription antibiotics on UK broiler farms. The Journal of Antimicrobial Chemotherapy 2008, 61(4):947-952.
26. Jacoby G., Bush K. β-Lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes 2012, (2012), http://www.lahey.org/Studies/. Tuesday, July 17, 2012.
27. Jarlier V., Nicolas M.H., Fournier G., Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 1988, 10(4):867-878.
28. Jouini A., Vinué L., Slama K.B., Saenz Y., Klibi N., Hammami S., et al. Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. The Journal of Antimicrobial Chemotherapy 2007, 60(5):1137-1141.
29. Kojima A., Ishii Y., Ishihara K., Esaki H., Asai T., Oda C., et al. Extended-spectrum-beta-lactamase-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: Report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrobial Agents and Chemotherapy 2005, 49(8):3533-3537.
30. Komatsu M., Aihara M., Shimakawa K., Iwasaki M., Nagasaka Y., Fukuda S., et al. Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan. Diagnostic Microbiology and Infectious Disease 2003, 46(2):125-130.
31. Leverstein-van Hall M.A., Dierikx C.M., Cohen Stuart J., Voets G.M., van den Munckhof M.P., van Essen-Zandbergen A., et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clinical Microbiology and Infection 2011, 17(6):873-880.
32. Lewis J.S., Herrera M., Wickes B., Patterson J.E., Jorgensen J.H. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrobial Agents and Chemotherapy 2007, 51(11):4015-4021.
33. Livermore D.M., Cantón R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., et al. CTX-M: Changing the face of ESBLs in Europe. The Journal of Antimicrobial Chemotherapy 2007, 59(2):165-174.
34. Mattar S., Martínez P. Emergence of antimicrobial resistance to extended-spectrum-β-lactamases (ESBL): Detection, clinic impact and epidemiology. Asociación Colombiana de Infectología 2007, 11(1):23-35.
35. Mugnaioli C., Luzzaro F., De Luca F., Brigante G., Perilli M., Amicosante G., et al. CTX-M-type extended-spectrum beta-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem. Antimicrobial Agents and Chemotherapy 2006, 50(8):2700-2706.
36. Naas T., Poirel L., Nordmann P. Minor extended-spectrum beta-lactamases. Clinical Microbiology and Infection 2008, 14(Suppl. 1):42-52.
37. Oliver A., Coque T.M., Alonso D., Valverde A., Baquero F., Cantón R. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrobial Agents and Chemotherapy 2005, 49(4):1567-1571.
38. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. The American Journal of Medicine 2006, 119(6 Suppl. 1):S20-28. (discussion S62-70).
39. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: A clinical update. Clinical Microbiology Reviews 2005, 18(4):657-686.
40. Philippon A., Arlet G., Lagrange P.H. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 1994, 13(Suppl. 1):S17-S29.
41. Pitout J.D., Gregson D.B., Church D.L., Elsayed S., Laupland K.B. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. Journal of Clinical Microbiology 2005, 43(6):2844-2849.
42. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. The Journal of Antimicrobial Chemotherapy 2005, 56(1):52-59.
43. Qin X., Zerr D.M., Weissman S.J., Englund J.A., Denno D.M., Klein E.J., et al. Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: A children's hospital experience. Antimicrobial Agents and Chemotherapy 2008, 52(11):3909-3914.
44. Romero L., López L., Rodríguez-Baño J., Ramón Hernández J., Martínez-Martínez L., Pascual A. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Clinical Microbiology and Infection 2005, 11(8):625-631.
45. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Catry B., et al. Diversity of extended-spectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli isolates in Belgian broiler farms. Antimicrobial Agents and Chemotherapy 2008, 52(4):1238-1243.
46. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Herman L., et al. Broad-spectrum beta-lactamases among Enterobacteriaceae of animal origin: Molecular aspects, mobility and impact on public health. FEMS Microbiology Reviews 2009, 34:295-316.
47. Torres C., Zarazaga M. ESBL in animals and their importance in transmission to humans. Enfermedades Infeccosas y Microbiología Clínica 2007, 25(Suppl. 2):29-37.
48. Vinué L., Saenz Y., Martínez S., Somalo S., Moreno M.A., Torres C., et al. Prevalence and diversity of extended-spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clinical Microbiology and Infection 2009, 15(10):954-957.
49. Wang H.H., Manuzon M., Lehman M., Wan K., Luo H., Wittum T.E., et al. Food commensal microbes as a potentially important avenue in transmitting antibiotic resistance genes. FEMS Microbiology Letters 2006, 254(2):226-231.
50. Woodford N., Fagan E.J., Ellington M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. The Journal of Antimicrobial Chemotherapy 2006, 57(1):154-155.